Andrew Left's Citron Research (http://www.citronresearch.com/) (formally known as Stocklemon.com) seeks to expose companies whose management is in some way misleading investors. Left digs into SEC filings, financials, management histories and other data to uncover such situations, and he is usually short the stocks he writes about. Mr. Left has been publishing for 7 years and has created a track record that is unrivaled in short selling. Mr. Left has been cited in Barron's, Wall St Journal, CNBC and other major publications repeatedly for his work. Mr. Left was also an invited speaker at the reknown Master Investor Conference.
Visit: Citron Research (http://www.citronresearch.com/)
Muddy Waters, LLC is a pioneer in on-the-ground, freely published investment research. Muddy Waters peels back the layers, often built up by seemingly respected but sycophantic law firms, auditors, and venal managements. We assess companies’ true worths. Our research approach is to combine diverse talents–many of whom have hands-on experience running businesses in the US and emerging markets.
We are a group of sophisticated investors with experience in patent litigation, experimental economics, corporate finance and responsible corporate governance. Our member’s comments are carried online by publications such as The Wallstreet Journal, Reuters, CNN, Seeking Alpha and Motley Fool.
PatentPlay realtime member editorials are broadcast by Rallythevote.com.
Patentplays™ is a Trademark with Pending US Registration, all rights reserved.
PropThink is an intelligence service that delivers long and short trading ideas to investors in the healthcare and life sciences sectors. Our Editorial Team is comprised of individuals with a strong background in science, medicine and the business of successfully commercializing therapeutics, medical devices, diagnostics and healthcare services. Our ultimate objective is to leverage the knowledge, experience, and relationships of our contributors to introduce our subscribers to profitable long and short investment opportunities in the healthcare sector.
Successfully trading, and investing in emerging growth healthcare companies is a difficult task. Over 90% of drugs never make it out of the clinic. Huge capital requirements along the way result in highly dilutive equity financings often done on the backs of retail investors. At PropThink, we believe that due diligence is the key to success in this industry. We leverage a combined 50 years of experience in science, medicine, legal, regulatory affairs, finance, and operational industry experience to analyze companies at a highly technical level. This detailed analysis and due diligence process defines our editorial strategy and provides our subscribers a high level of confidence in our research. Our focus is on identifying and analyzing technically-complicated companies and equities that are grossly over or under-valued.
Visit PropThink.com to see all of our coverage and research, and subscribe to our free newsletter to receive reports, articles, and trading alerts.
Andrew Sheehy holds the position of Chief Analyst at Generator Research.
Including over 20 years operational experience in the technology sector, Mr Sheehy's professional repertoire is unusually broad and encompasses: technology design and development in the fields of RF & microwave electronics and, most recently, software engineering; telecoms product management & marketing; market research (client side and agency side) and new business development.
In former years, Mr Sheehy has held the position of Principal Engineer at Nortel Networks, Senior Product Manager at Telstra New Zealand and Director of Product Management at the WiMax vendor, PipingHot Networks, which became Orthogon Systems and, having been acquired by Motorola in 2007 was subsequently divested to become what is now Cambium Networks.
Mr Sheehy holds a B.Sc. (Hons) degree in Electronics from Salford University. He also holds an MBA degree from London Business School.
Amigobulls.com specializes in creating stock analysis videos. These short videos give investors deep insights into key numbers they should be looking at. Apart from our algorithmic analysis there are very interesting user contributed videos which provide unique perspective about stocks. We also offer stock picks from internet industry based on fundamental analysis and technical analysis. Join our community to contribute to amigobulls.com or have lively discussions about stocks.
Giverny - the color of money...and my old Landrover. Lifelong technology stock investor who has significant experience working with private and public technology companies in both executive and management consulting roles. Writing research is perhaps one of the best ways to make sure I understand the stocks I am investing in. I follow the blue chips to make sure I understand the sector dynamics and usually invest in small or mid caps, or just generally under-priced stocks, in order to profit.
Follow us on Twitter @GivernyResearch
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future.
QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. The content we provide via Seeking Alpha may be part of our efforts to widen a client’s exposure. To read our full disclaimer, visit http://disclaimer.qualitystocks.net.
I am an activist investor in US and Chinese stocks. I was previously an investment banker in New York Hong Kong and London for 9 years, focused on Equity Capital Markets. I look at both long ideas and short ideas and typically focus on a small number on names where I can spend the time to conduct very deep research. I spend my time living between Los Angeles and Beijing, China.